NCT04510701

Brief Summary

This case series will recruit patients who require lateral maxillary sinus floor elevation surgery. This procedure will be carried out as per standard surgical protocol. The periodontal resident performing the surgery will evaluate the Schneiderian membrane at several points during the surgery to determine its integrity (beyond visual inspection). This will be completed by using the videoscope to evaluate the membrane. This evaluation will take place at at least 3 points during the surgery (before membrane elevation, half-way through membrane elevation, and prior to initiating bone grafting procedures). If the resident wishes to evaluate the membrane at other points during the surgery to inspect the integrity of the membrane, this may be accomplished. This evaluation will be recorded for later, further evaluation by experienced periodontists. If no visible perforation is evident, a 1% baby shampoo solution in normal saline (Johnson and Johnson) will be applied topically over the membrane prior to videoscope evaluation. At this point, the patient will lightly blow their nose; if any micro-tears not visible to the naked eye are present, these tears will produce a bubbling effect, which will be recorded by the videoscope. This evaluation will take place with the 1st and 2nd videoscope evaluations (before membrane elevation, and mid-way through elevation). Patients will be asked to complete a VAS questionnaire at their one-week follow-up appointment in order to determine how post-op healing has been progressing. After all procedures have been performed, three experienced periodontists will individually evaluate the videos post-surgically. They will evaluate each video and determine if, in their opinion, there is a membrane perforation (yes/no). Each video will be evaluated in a random fashion (each video being evaluated as a separate event, and not by case). The evaluating periodontists will also be masked to the results noted by the surgeon who completed the surgery, and blinded to the patient's information.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 9, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 12, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

January 6, 2022

Status Verified

January 1, 2022

Enrollment Period

1.2 years

First QC Date

August 9, 2020

Last Update Submit

January 5, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • incidence of micro-tears present in the Schneiderian membrane

    incidence of micro-tears will be evaluated at 3 points during the surgery

    first evaluation will be done before the membrane is elevated; second will be part-way through elevation of the membrane; and the third evaluation will be once membrane elevation has been completed

Interventions

a videoscope will be used to evaluate the integrity of the membrane while doing lateral maxillary sinus elevation surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients of the Dr. Sam Borden Graduate Periodontics Clinic, Dr. Gerald Niznick College of Dentistry, University of Manitoba who require lateral sinus floor elevation surgery.

You may qualify if:

  • Patients requiring maxillary sinus floor elevation (lateral approach), with current subantral bone height 6 mm or less
  • Male or female patient, 18 years of age and older
  • Patients who exhibit adequate ability to comply with postoperative instructions, research protocols and methods
  • Patients who have read, understand, and have signed the informed consent form
  • Patients with an adequate level of oral hygiene, defined as Full Mouth Plaque Score (FMPS) and Full Mouth Bleeding Score (FMBS) should be \<20% (after periodontal therapy, if necessary)

You may not qualify if:

  • Absolute contraindications:
  • Patients on IV bisphosphonates
  • Patients who are undergoing chemotherapy
  • Patients who have undergone head and neck radiotherapy where the field of irradiation included the maxilla
  • Patients whose membrane thickness is increased due to an existing sinus pathology (sinusitis or mucosal cysts): These conditions should be treated prior to surgical treatment (S. W. Kim et al. 2019)
  • Diabetic patients with uncontrolled diabetes and poor glycemic control
  • Patients who are undergoing long-term immunosuppressive therapy, or have been taking corticosteroids long-term (Bornstein et al. 2009)
  • Patients with active or untreated periodontitis
  • Relative contraindications:
  • Patients who have been receiving long term oral bisphosphonate therapy (3 years duration or more) (Bornstein et al. 2009)
  • Patients who smoke \>10 cigarettes per day
  • Patients who are alcohol abusers (Li and Wang 2008)
  • Patients who are on antithrombotic medications should be treated with extra caution during surgery, as well as patients with blood disorders that may affect hemostasis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Manitoba

Winnipeg, Manitoba, Canada

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 9, 2020

First Posted

August 12, 2020

Study Start

November 1, 2020

Primary Completion

January 1, 2022

Study Completion

January 1, 2022

Last Updated

January 6, 2022

Record last verified: 2022-01

Locations